What are the criteria that you apply when deciding somebody is competent to make an informed decision about their own health? How do you actually do this in the field with the sort of case we’ve just been talking about? https://youtu.be/zcQpII560g0

Conduct research on the United States Supreme Court case of Cruzan v. Director, Missouri Department of Health, 497 U.S. 261 (1990). The full text of this case, along with numerous case briefs, commentaries, summaries, etc., may be found by simply entering the full name of the case into any major online search engine of your choosing. Alternatively, you may use Westlaw, Lexis or any other professional legal research databank in your research, however, use of such is not required. Following your research, review the following questions: What was the ultimate numerical vote of the court? When and how can life support be withdrawn? How does death by refusal of treatment differ from suicide? How does a living will work and when does it become of legal effect? What is a health care directive and how does it work? After completing your research, summarize your answers, and, along with any other sources, if any, address and support your particular position/view on the following specific issues, and, specifically, how you would apply the Saint Leo University Core Values of Community, Respect, and Integrity into your actions. Be sure to use proper APA format for citations. 1. What are the potential foreseeable financial, psychological, and medical, yet unintended, harmful consequences to ones family and friends in failing to provide a properly executed will and living will prior to ones final illness and death? 2. What are the fundamental distinctions between recuperative medical care and palliative care? Who should be included in the decision to modify care from recuperative to palliative? When, if ever, is the right to refuse any and all medical care appropriate when such virtually ensures the death of the patient? 3. What professionals, medical or otherwise, should be involved in advising decisions concerning end-oflife wishes? How does euthanasia differ from a simple cessation of treatment? Who should make end of life decisions for those who are without a family member to take on such a role? 4. What measures can be taken to ensure the quality of ongoing family and social relationships, individually and as a group, to end-of-life patients? What pitfalls are to be avoided in ensuring maintenance of these relationships? What actions may be taken to ensure the spiritual and existential dimensions of the process are respected and integrated?
Show more
You are a single parent of two children: a 7-year-old and a 9-year-old. You are also a licensed psychologist. You have had the same live-in caretaker, Angela, for your children since they were born. Angela tells you that her teenage daughter has been having nightmares and believes that having a pet dog to sleep in her room with her would help her. The problem is that they live in a pet free apartment complex. Angela has heard that if her daughter is diagnosed with some kind of disability, she will be allowed to have an emotional support dog. She asks you to write a letter to the management company. If you agree to write that letter, will you be doing any harm? Discuss this issue and the potential violation of at least five APA Ethics Standards. Be sure to incorporate information from the article by Ensminger and Thomas (2013) on some of the implications of writing that letter. Support this paper with at least five scholarly and professional resources. In addition to these specified resources, other appropriate scholarly resources, including older articles, may also be included.
This project is in MSc biomedical science and depends on Oxford nanopore sequence with MinION and bioinformatics tool, which were used is canu, nanpolish from albacore. This aims of this study are : 1- Generate complete genome sequence by using MinIon sequence( main aim) 2- apply antibiotics susceptibilities testing (side aim) 3- identify virulece factor and resistance gene by using NCBI, BLAST, Islandveiwer and VFDB. To date there have been no studies investigating antibiotic resistance gene profiles of S. rostri obtained from bigs, and there is no evidence of its pathogenicity in humans. Nevertheless, a determination of the genetic basis to multidrug resistance demonstrated by S. rostri by whole genome sequencing could provide more information regarding the expression of resistance genes and those encoding virulence factors by S. rostri. Overall, the study to be relayed in following chapters may provide an insight into whether, as Stegmann and Perreten (2010) suggest, S. rostri potentially provides a reservoir of resistance genes for pathogenic staphylococci. Therefore, the aims of the project are determining the whole genome sequence of S. rostri strain ARI 602 (DSM21969), providing an antibiotic susceptibility profile of S. rostri strain ARI 602 (DSM21969), identifying virulence genes in S. rostri strain ARI 602 (DSM21969) and comparing the genome of S. rostri strain ARI 602 (DSM21969) with the other genotype.